RxDoctor Payments Data

Jennifer Feldman, MD

Clinical Cardiac Electrophysiology · Columbia, SCNPI 1407855182

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (49.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Abbott at 46.4% of the total. Reporting peaked in 2022 at $4,854 and has fallen 67.4% since, to $1,583 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in SC, where the typical reported total is $35,448.

$18,586in general payments, 2019–2025

Across 274 payments — averaging $67.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$9K
  • Medtronic$3K
  • Altathera Pharmaceuticals LLC$2K
  • Boston Scientific$1K
  • Novartis$780
  • E.r. Squibb & Sons, L.L.C.$491
  • plus $3K from 23 others

What the payments were for

  • Consulting fees$1,7509%
  • Speaking & faculty fees$500%
  • Travel & lodging$7,59941%
  • Food & beverage$9,18649%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,586 in reported general payments places this provider in the 35th percentile of 58 clinical cardiac electrophysiology providers in South Carolina.

See all clinical cardiac electrophysiology providers in South Carolina

Medicare billing

Part B allowed, 2024
$380,827
Medicare patients
2,259
Services billed
7,913

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban191$178,092
XareltoRivaroxaban52$50,319
Repatha SureclickEvolocumab25$23,570
JardianceEmpagliflozin13$14,211
EntrestoSacubitril/Valsartan11$8,831
Metoprolol Succinate152$2,479
Flecainide Acetate52$2,299
SotalolSotalol Hcl81$1,498
Rosuvastatin Calcium61$1,443
Atorvastatin Calcium48$770
Losartan Potassium45$728
Warfarin Sodium39$666
Carvedilol61$572
Amiodarone Hcl21$475
Digoxin16$398

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$47$178,092191 claims
Johnson & JohnsonXarelto$304$50,31952 claims
Boehringer IngelheimJardiance$263$14,21113 claims
NovartisEntresto$780$8,83111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 58 clinical cardiac electrophysiology providers in South Carolina.

Other clinical cardiac electrophysiology in Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →